About the Projects
The concept of these projects is to provide essential medications for patients with thalassemia and hereditary blood disorders registered in the treatment centers, ensuring their availability throughout the year. When funding becomes available, priority is given to the essential therapeutic items necessary for the patients’ health, or some of them. These medications are purchased according to specifications and standards in coordination with official authorities, then supplied and distributed to patients based on priority needs.
Justifications for Pharmaceutical Relief Projects
Thalassemia and hereditary blood disorder patients require essential medications for life.
Some therapeutic items, especially iron chelation drugs, are expensive and cannot be afforded by the patients or their families, with some households having multiple patients, particularly in the face of difficult economic conditions.
In the event of a shortage of these essential medications, patients face severe complications, which may result in death.